Article Figures & Data
Figures
- FIGURE 1.
(A and B) Dosimetry results for patients A (A) and B (B), when performed by 2 MPs using same dosimetry methods. (C and D) Percentage difference in ADs between 2 MPs for patients A (C) and B (D). PD = percentage difference.
- FIGURE 2.
Range of ADs per organ for all possible combinations of VOI formats and scan time point used for patient A. “All Liver Results” illustrates range of liver AD results when results from both scenarios—with and without lesions included inside liver—were combined.
- FIGURE 3.
QCD for all possible 18 combinations of VOI formats and time points, with or without mass scaling, or using average mass for mass scaling, used to yield ADs in Figure 2. Furthermore, combination of all liver results—with and without lesions included—are given in “All Liver Results.”
- FIGURE 4.
Mean AD per region for different methods that were used for calculation. Number of submissions that included each method is provided in Table 1. LD = local deposition; MC = MC dosimetry simulations; OSV = organ S value; VSV = voxel S value–based dosimetry.
- FIGURE 5.
Mean AD per region using different available software solutions for all regions of patients A and B. OS = open-source/freely available and well-validated dosimetry non-CS, including in-house solutions.
- FIGURE 6.
QCD per organ for different dosimetry methods. LD = local deposition; MC = MC dosimetry simulations.
- FIGURE 7.
QCD per organ for different dosimetry software. OS = open-source/freely available dosimetry software, including in-house solutions and well-validated software.
Tables
Parameter Submissions (n) Dosimetry method OSV 10 VSV 9 Local deposition (organ and voxel level) 4 MC simulation 2 Dosimetry software Noncommercial 15 CS 1 4 CS 2 3 CS 3 2 CS 4 1
Supplemental Data
Files in this Data Supplement:
